|
GSK may get EU green light for new biotech asthma drug this week
Reuters Nucala is first in new drug class for severe asthma. * EMA weighs verdict on Nucala at Sept. 21-24 meeting. By Ben Hirschler. LONDON, Sept 23 (Reuters) – GlaxoSmithKline may get a green light from European regulators as early as this week for a new … |
View full post on asthma – Google News